Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study.
Blant JC, De Rossi NN, Gold R, Maurousset A, Kraemer M, Romero-Pinel L, Misu T, Ouallet JC, Pallix Guyot M, Gerevini S, Bakirtzis C, Piñar Morales R, Vlad B, Karypidis P, Moisset X, Derfuss TJ, Jelcic I, Martin-Blondel G, Ayzenberg I, McGraw C, Laplaud DA, Du Pasquier RA, Bernard-Valnet R; for CORPUS and Italian study groups. Blant JC, et al. Among authors: bakirtzis c. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200281. doi: 10.1212/NXI.0000000000200281. Epub 2024 Jul 11. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38991170 Free PMC article.
Therapeutic application of rTMS in neurodegenerative and movement disorders: A review.
Pateraki G, Anargyros K, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Ziogka P, Sgantzos M, Folia V, Peristeri E, Dardiotis E. Pateraki G, et al. Among authors: bakirtzis c. J Electromyogr Kinesiol. 2022 Feb;62:102622. doi: 10.1016/j.jelekin.2021.102622. Epub 2021 Nov 26. J Electromyogr Kinesiol. 2022. PMID: 34890834 Review.
CNS Ageing in Health and Neurodegenerative Disorders.
Kesidou E, Theotokis P, Damianidou O, Boziki M, Konstantinidou N, Taloumtzis C, Sintila SA, Grigoriadis P, Evangelopoulos ME, Bakirtzis C, Simeonidou C. Kesidou E, et al. Among authors: bakirtzis c. J Clin Med. 2023 Mar 14;12(6):2255. doi: 10.3390/jcm12062255. J Clin Med. 2023. PMID: 36983254 Free PMC article. Review.
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Boziki MK, Karapanayotides T, Papadopoulos G, Lagoudaki R, Melo P, Bakirtzis C, Nikolaidis I, Gounari E, Tsavdaridou V, Skoura L, Afrantou T, Tatsi T, Grigoriadou E, Polyzoidou E, Mandoras N, Giantzi V, Kalogera-Fountzila A, Ioannidis P, Parissis D, Pelidou SH, Zoidou S, Grigoriadis N. Boziki MK, et al. Among authors: bakirtzis c. Neurol Res. 2020 Mar;42(3):209-221. doi: 10.1080/01616412.2020.1722913. Epub 2020 Feb 12. Neurol Res. 2020. PMID: 32048570
The Role of Diet and Interventions on Multiple Sclerosis: A Review.
Stoiloudis P, Kesidou E, Bakirtzis C, Sintila SA, Konstantinidou N, Boziki M, Grigoriadis N. Stoiloudis P, et al. Among authors: bakirtzis c. Nutrients. 2022 Mar 9;14(6):1150. doi: 10.3390/nu14061150. Nutrients. 2022. PMID: 35334810 Free PMC article. Review.
Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response.
Boziki M, Bakirtzis C, Sintila SA, Kesidou E, Gounari E, Ioakimidou A, Tsavdaridou V, Skoura L, Fylaktou A, Nikolaidou V, Stangou M, Nikolaidis I, Giantzi V, Karafoulidou E, Theotokis P, Grigoriadis N. Boziki M, et al. Among authors: bakirtzis c. Cells. 2022 Jun 17;11(12):1959. doi: 10.3390/cells11121959. Cells. 2022. PMID: 35741088 Free PMC article.
102 results